The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Volasertib (BI 6727) - ≥97%, high purity , CAS No.755038-65-4, Inhibitor of polo like kinase 1
Basic Description Synonyms Volasertib|755038-65-4|BI 6727|Volasertib (BI 6727)|BI-6727|BI6727 (Volasertib)|Volasertib [USAN]|Volasertib(BI6727)|BI6727|6EM57086EA|Volasertib (USAN)|N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo Specifications & Purity ≥97% Storage Temp Store at -20°C Shipped In Dry ice Grade Moligand™ Action Type INHIBITOR Mechanism of action Inhibitor of polo like kinase 1 Product Description Volasertib(BI6727) is a highly potent PLK1 inhibitor with an IC50 of 0.87 nM; shows 6- and 65-fold greater selectivity against Plk2 and Plk3.
Names and Identifiers IUPAC Name N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide INCHI InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1 InChi Key SXNJFOWDRLKDSF-XKHVUIRMSA-N Canonical SMILES CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C Isomeric SMILES CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C PubChem CID 10461508 Molecular Weight 618.83
Chemical and Physical Properties Solubility DMSO 50 mg/mL Water <1 mg/mL Ethanol 124 mg/mL Refractive Index 1.63
Safety and Hazards(GHS) Pictogram(s) GHS06 , GHS08 , GHS07 Signal Danger Hazard Statements H315: Causes skin irritation
H319: Causes serious eye irritation
H373: Causes damage to organs through prolonged or repeated exposure
H300: Fatal if swallowed
H361: Suspected of damaging fertility or the unborn child
Precautionary Statements P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.
P280: Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352: IF ON SKIN: wash with plenty of water.
P321: Specific treatment (see ... on this label).
P405: Store locked up.
P501: Dispose of contents/container to ...
P264: Wash hands [and …] thoroughly after handling.
P260: Do not breathe dust/fume/gas/mist/vapors/spray.
P270: Do not eat, drink or smoke when using this product.
P362+P364: Take off contaminated clothing and wash it before reuse.
P330: Rinse mouth.
P203: Obtain, read and follow all safety instructions before use.
P264+P265: Wash hands [and …] thoroughly after handling. Do not touch eyes.
P301+P316: IF SWALLOWED: Get emergency medical help immediately.
P318: if exposed or concerned, get medical advice.
P337+P317: If eye irritation persists: Get medical help.
P332+P317: If skin irritation occurs: Get medical help.
P319: Get medical help if you feel unwell.
References 1. Barr FA, Silljé HH, Nigg EA. (2004) Polo-like kinases and the orchestration of cell division.. Nat Rev Mol Cell Biol, 5 (6): (429-40). [PMID:15173822 ] 2. Santamaria A, Neef R, Eberspächer U, Eis K, Husemann M, Mumberg D, Prechtl S, Schulze V, Siemeister G, Wortmann L et al. . (2007) Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis.. Mol Biol Cell, 18 (10): (4024-36). [PMID:17671160 ] 3. Schöffski P. (2009) Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology.. Oncologist, 14 (6): (559-70). [PMID:19474163 ]
Solution Calculators Molarity Calculator Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
C1720101